How much of ADM's fiscal 2005 earnings growth was driven by one-time items rather than core operations?

A significant share. The jump in net earnings from $495 million to $1.04 billion was largely due to the absence of the $400 million fructose settlement charge, which accounts for most of the comparison. Other non-recurring items included a $114 million LIFO inventory benefit, a $45 million equity share of the CIP gain, and $114 million in realized gains from selling Tate & Lyle shares. Excluding these gains, segment operating profit actually declined slightly, from $1.56 billion to $1.55 billion.

Why did ADM's Corn Processing segment underperform in fiscal 2005?

Corn Processing operating profit fell 20% to $530 million. Higher net corn and energy costs squeezed margins in sweeteners and starches, and lower lysine selling prices hurt Bioproducts, as increased Chinese supply pushed prices down. Strong ethanol prices partially offset these pressures.

Is ADM's balance sheet in good shape, and can it return cash to shareholders?

Yes. Equity rose to $8.4 billion, long-term debt-to-capital fell to 30%, and the company had $3.1 billion of unused credit lines plus $567 million of cash and short-term securities. Operating cash flow of $2.1 billion funded $1.4 billion of debt reduction and $139 million of buybacks, with dividends increased to $0.32 per share from $0.27. The board also authorized up to 100 million shares of repurchases through 2009, with about 93 million remaining at fiscal year end.

What are the main risks and contingent liabilities disclosed in the filing?

Key risks include commodity price volatility, weather, government farm policies, and foreign currency exposure, especially to the euro and British pound. ADM has about $422 million of debt guarantees, mainly for equity affiliates, with $309 million outstanding. It is a potentially responsible party in about 25 Superfund matters with uncertain cleanup costs, and expects a USEPA civil penalty above $1 million over Vitamin E plant compliance issues, which management does not consider material. Commitments include about $1.1 billion to complete approved capital projects and acquisitions.

ADM 10-K FY2005 Annual Report — Revenue, Net Income, EPS

01—Abstract

Summary

Summary of the 10-K filed September 9, 2005. Cited figures are marked; the original filing is the authoritative source.

Archer-Daniels-Midland's fiscal 2005 (year ended June 30, 2005) was a strong rebound year.

Net earnings rose to $1.04 billion^a ($1.59 diluted EPS) from $495 million ($0.76) in fiscal 2004, a gain of roughly 111%. The improvement was driven mainly by the absence of the prior year's $400 million fructose litigation settlement, a $114 million LIFO inventory benefit (versus a $119 million charge a year earlier), a $45 million equity share of a gain at affiliate CIP from the sale of its Tate & Lyle stake, and $114 million of realized securities gains from ADM's own Tate & Lyle sale. Revenue was essentially flat at $35.9 billion, down about 0.6%, as lower agricultural commodity prices offset currency gains.

Pretax earnings from operations, excluding corporate items, were more modest: total segment operating profit fell slightly to $1.55 billion^b from $1.56 billion, with Corn Processing down 20% on higher corn and energy costs and weaker lysine prices, while Oilseeds Processing (up 19%), Agricultural Services (up 5%) and Other (up 15%) improved. Balance sheet and cash flow strengthened considerably. Operating cash flow was $2.1 billion versus $33 million a year earlier, driven by working capital releases as commodity prices fell.

ADM used the cash to repay $1.4 billion^c of line-of-credit borrowings, buy back $139 million of stock, and pay $209 million in dividends. Shareholders' equity grew to $8.4 billion, and the long-term debt-to-capital ratio improved to 30% from 33%. Working capital was $4.3 billion with a current ratio of 1.8.

The company also disclosed a $1.1 billion^d commitment to complete approved capital projects and acquisitions, a $422 million guarantee exposure (of which $309 million was outstanding), and a 100 million share repurchase authorization running through 2009. For investors, the key questions are how much of fiscal 2005's earnings reflect durable operating strength versus one-time items. Several gains (Tate & Lyle sale, CIP gain, LIFO benefit) totaled roughly $270 million pretax and do not recur.

Management also flagged competitive pressure in lysine from Chinese supply, weak South American crush margins from industry overcapacity, and exposure to commodity price swings. The filing itself contains no forward-looking guidance, as the company incorporates its discussion by reference to the shareholder report.

02—Key points

Key Highlights

Net earnings up about 111% to $1.04 billion ($1.59 diluted EPS) from $495 million ($0.76), largely from lapping the $400 million fructose litigation settlement in the prior year.
Net sales were essentially flat at $35.9 billion (down 0.6%), with lower agricultural commodity prices offsetting $962 million of currency gains.
One-time items boosted results: a $114 million LIFO inventory benefit, a $45 million equity share of the CIP gain, and $114 million of realized gains on the Tate & Lyle PLC share sale.
Operating cash flow surged to $2.1 billion from $33 million, as working capital needs fell with commodity prices, funding $1.4 billion of debt paydown and $139 million of buybacks.
Segment performance was mixed: Oilseeds Processing (+19%), Agricultural Services (+5%) and Other (+15%) improved, while Corn Processing fell 20% on higher corn and energy costs and lower lysine prices.
Balance sheet strengthened: shareholders' equity reached $8.4 billion, long-term debt-to-capital fell to 30% from 33%, and working capital was $4.3 billion with a 1.8 current ratio.
Management flagged risks including Chinese lysine oversupply, South American crush-margin overcapacity, and a likely EPA civil penalty above $1 million for Vitamin E plant violations (not expected to be material).

03—Questions

Frequently Asked Questions

How much of ADM's fiscal 2005 earnings growth was driven by one-time items rather than core operations?
A significant share. The jump in net earnings from $495 million to $1.04 billion was largely due to the absence of the $400 million fructose settlement charge, which accounts for most of the comparison. Other non-recurring items included a $114 million LIFO inventory benefit, a $45 million equity share of the CIP gain, and $114 million in realized gains from selling Tate & Lyle shares. Excluding these gains, segment operating profit actually declined slightly, from $1.56 billion to $1.55 billion.
Why did ADM's Corn Processing segment underperform in fiscal 2005?
Corn Processing operating profit fell 20% to $530 million. Higher net corn and energy costs squeezed margins in sweeteners and starches, and lower lysine selling prices hurt Bioproducts, as increased Chinese supply pushed prices down. Strong ethanol prices partially offset these pressures.
Is ADM's balance sheet in good shape, and can it return cash to shareholders?
Yes. Equity rose to $8.4 billion, long-term debt-to-capital fell to 30%, and the company had $3.1 billion of unused credit lines plus $567 million of cash and short-term securities. Operating cash flow of $2.1 billion funded $1.4 billion of debt reduction and $139 million of buybacks, with dividends increased to $0.32 per share from $0.27. The board also authorized up to 100 million shares of repurchases through 2009, with about 93 million remaining at fiscal year end.
What are the main risks and contingent liabilities disclosed in the filing?
Key risks include commodity price volatility, weather, government farm policies, and foreign currency exposure, especially to the euro and British pound. ADM has about $422 million of debt guarantees, mainly for equity affiliates, with $309 million outstanding. It is a potentially responsible party in about 25 Superfund matters with uncertain cleanup costs, and expects a USEPA civil penalty above $1 million over Vitamin E plant compliance issues, which management does not consider material. Commitments include about $1.1 billion to complete approved capital projects and acquisitions.

04—Continue

← View all 10-K filings